Official 2024 U.S. DOL Form 5500 summary for Halozyme, INC. (Halozyme Therapeutics, INC. 401(k) Plan · EIN 33-0802801 · PN 001): $79.86M net assets, 353 active participants, and Sponsor-paid or unbenchmarked.
| Plan Sponsor | Halozyme, INC. |
|---|---|
| Filing Identifier | Halozyme Therapeutics, INC. 401(k) Plan · EIN 33-0802801 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (CA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $79.86M |
| Active Participants | 353 |
| Direct Admin Fee Rate | Sponsor-paid or unbenchmarked |
| Cohort Peer Median | N/A |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI